UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027357
Receipt number R000031334
Scientific Title Prospective study for efficacy and safety of capsule endoscopy in children
Date of disclosure of the study information 2017/05/16
Last modified on 2017/05/16 11:49:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective study for efficacy and safety of capsule endoscopy in children

Acronym

Prospective study for pediatric capsule endoscopy

Scientific Title

Prospective study for efficacy and safety of capsule endoscopy in children

Scientific Title:Acronym

Prospective study for pediatric capsule endoscopy

Region

Japan


Condition

Condition

Small bowel diseases

Classification by specialty

Gastroenterology Gastrointestinal surgery Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the actual condition of use of capsule endoscopes in children in Japan, and to study its usefulness and safety prospectively in multiple facilities.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Total small intestine observation rate

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

0 years-old <=

Age-upper limit

18 years-old >

Gender

Male and Female

Key inclusion criteria

Among Inpatients or outpatients in the hospitals which participate this study, patients who are suspected to have small bowel disease or have known small intestinal diseases, and who will receive capsule endoscopy.
1. Patients younger than 18 years at the time of consent
2. Patients with their or their legal representative's written consent under the free will and sufficient understanding after receiving enough explanation for the participation in this study

Key exclusion criteria

1. Abdominal X-ray examination, abdominal ultrasound examination, history of history, surgical history, clinical findings or other information sugest gastrointestinal obstruction or fistulas.
2. A patient with obvious intestinal stenosis which is expected to cause capsule retention.
3. A patient in which a cardiac pacemaker or other electro-medical device is implanted.
4. A patient with a history of barium-sulfate-induced allergy (for the patients who will recieve patency capsule.
5. patients whom research director or research collaborator judged inappropriate as subjects

Target sample size

200


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tsuyoshi Sogo

Organization

Saiseikai Yokohama City Tobu Hospital

Division name

Department of Pediatric Hepatology and Gastroenterology

Zip code


Address

3-6-1, Shimosueyoshi, Tsurumi-ku, Yokohama, Kanagawa, Japan

TEL

045-576-3000

Email

t_sogo@tobu.saiseikai.or.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tsuyoshi Sogo

Organization

Saiseikai Yokohama City Tobu Hospital

Division name

Department of Pediatric Hepatology and Gastroenterology

Zip code


Address

3-6-1, Shimosueyoshi, Tsurumi-ku, Yokohama, Kanagawa, Japan

TEL

045-576-3000

Homepage URL


Email

t_sogo@tobu.saiseikai.or.jp


Sponsor or person

Institute

Saiseikai Yokohama City Tobu Hospital

Institute

Department

Personal name



Funding Source

Organization

self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 05 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2017 Year 01 Month 23 Day

Date of IRB


Anticipated trial start date

2017 Year 05 Month 16 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

1. age, sex, height, body mass index (BMI), history of abdominal surgery
2. purpose of capsule endoscopy (CE)
3. Gastrointestinal endoscopy before CE
4. Balloon asisted enteroscopy
5. Diagnosis before CE and final diagnosis
6. Results of capsule endoscopy
7. Capability of swallowing capsule endoscopy, time for swallowing CE or patency capsule
8. Methods for preperation
9. Intervention after starting CE
10. Grade of bowel cleansing
11. contribution of CE
12. Usage og real time viewer
13. Methods for introducing CE (in cases that patients cannot swallow CE)
14. Time for introducing CE (in cases that patients cannot swallow CE)
15. Outcome and CE retention
16. Adverse events
17. Serum citrulline level
18. serum prealbumin level
19. serum transferrin level
20. serum and urin uric acid and creatinine level, and urinary specific gravity
21. Lewis Score


Management information

Registered date

2017 Year 05 Month 16 Day

Last modified on

2017 Year 05 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031334


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name